Uchenna O. Njiaju

Integration of Cell Line and Clinical Trial Genome-Wide Analyses Supports a Polygenic Architecture of Paclitaxel-Induced Sensory Peripheral Neuropathy

Heather E. Wheeler, Eric R. Gamazon, Claudia Wing et al. · Clinical Cancer Research · 2012 · 59 citations · Full text

Whole-genome studies identify solute carrier transporters in cellular susceptibility to paclitaxel

Uchenna O. Njiaju, Eric R. Gamazon, Lidija K. Gorsic et al. · Pharmacogenetics and Genomics · 2012 · 35 citations · Full text

Circadian variation in plasma 5-fluorouracil concentrations during a 24 hour constant-rate infusion

Gini F. Fleming, L. Philip Schumm, Greg Friberg et al. · BMC Cancer · 2015 · 27 citations · Full text

Neo‐adjuvant Capecitabine Chemotherapy in Women with Newly Diagnosed Locally Advanced Breast Cancer in a Resource‐poor Setting (Nigeria): Efficacy and Safety in a Phase II Feasibility Study

Olukayode Arowolo, Uchenna O. Njiaju, Temidayo O. Ogundiran et al. · The Breast Journal · 2013 · 19 citations · Full text

Treatment of therapy-related myeloid neoplasms with high-dose cytarabine/mitoxantrone followed by hematopoietic stem cell transplant

Lucy A. Godley, Uchenna O. Njiaju, Margaret Green et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2010 · 17 citations